2017 Q2 Form 10-Q Financial Statement
#000114420417027024 Filed on May 15, 2017
Income Statement
Concept | 2017 Q2 | 2017 Q1 | 2016 Q1 |
---|---|---|---|
Revenue | $1.210M | $1.007M | $568.0K |
YoY Change | 80.87% | 77.29% | 747.76% |
Cost Of Revenue | $850.0K | $901.0K | $670.0K |
YoY Change | 2.91% | 34.48% | 125.59% |
Gross Profit | $360.0K | $106.0K | -$102.0K |
YoY Change | -329.3% | -203.92% | -55.65% |
Gross Profit Margin | 29.75% | 10.53% | -17.96% |
Selling, General & Admin | $3.290M | $3.840M | $1.420M |
YoY Change | 68.72% | 170.42% | 115.15% |
% of Gross Profit | 913.89% | 3622.64% | |
Research & Development | $1.184M | $470.0K | $397.0K |
YoY Change | 127.26% | 18.39% | -55.04% |
% of Gross Profit | 328.89% | 443.4% | |
Depreciation & Amortization | $60.00K | $43.00K | $102.0K |
YoY Change | -33.33% | -57.84% | 29.11% |
% of Gross Profit | 16.67% | 40.57% | |
Operating Expenses | $4.478M | $4.311M | $1.821M |
YoY Change | 81.59% | 136.74% | 17.71% |
Operating Profit | -$4.118M | -$4.205M | -$1.923M |
YoY Change | 57.0% | 118.67% | 8.22% |
Interest Expense | $8.680M | -$1.210M | -$440.0K |
YoY Change | -706.99% | 175.0% | -414.29% |
% of Operating Profit | |||
Other Income/Expense, Net | $26.00K | -$1.208M | $734.0K |
YoY Change | -101.81% | -264.58% | 428.06% |
Pretax Income | $4.570M | -$5.410M | -$2.360M |
YoY Change | -212.56% | 129.24% | 43.9% |
Income Tax | |||
% Of Pretax Income | |||
Net Earnings | -$4.092M | -$5.413M | -$1.189M |
YoY Change | 0.86% | 355.26% | -27.41% |
Net Earnings / Revenue | -338.18% | -537.54% | -209.33% |
Basic Earnings Per Share | |||
Diluted Earnings Per Share | $7.746M | -$15.03M | -$9.077M |
COMMON SHARES | |||
Basic Shares Outstanding | 9.582M shares | 7.977M shares | 53.50M shares |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2017 Q2 | 2017 Q1 | 2016 Q1 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $4.100M | $3.100M | $8.300M |
YoY Change | -35.94% | -62.65% | 336.84% |
Cash & Equivalents | $3.898M | $2.817M | $8.267M |
Short-Term Investments | $200.0K | $200.0K | $100.0K |
Other Short-Term Assets | |||
YoY Change | |||
Inventory | $700.0K | $800.0K | $1.000M |
Prepaid Expenses | |||
Receivables | $400.0K | $500.0K | |
Other Receivables | $600.0K | $700.0K | |
Total Short-Term Assets | $5.862M | $5.100M | $10.20M |
YoY Change | -27.63% | -50.0% | 316.5% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $800.0K | $900.0K | $700.0K |
YoY Change | -20.0% | 28.57% | -25.13% |
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Total Long-Term Assets | $873.0K | $900.0K | $800.0K |
YoY Change | -12.7% | 12.5% | -17.95% |
TOTAL ASSETS | |||
Total Short-Term Assets | $5.862M | $5.100M | $10.20M |
Total Long-Term Assets | $873.0K | $900.0K | $800.0K |
Total Assets | $6.735M | $6.000M | $11.00M |
YoY Change | -25.99% | -45.45% | 221.26% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $1.000M | $1.500M | $600.0K |
YoY Change | 0.0% | 150.0% | -25.0% |
Accrued Expenses | |||
YoY Change | |||
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $2.800M | $2.700M | $1.489M |
YoY Change | 40.0% | 81.33% | -10.62% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | -100.0% | ||
Other Long-Term Liabilities | $0.00 | $0.00 | $1.900M |
YoY Change | -100.0% | -100.0% | -51.28% |
Total Long-Term Liabilities | $0.00 | $0.00 | $1.900M |
YoY Change | -100.0% | -100.0% | -71.21% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $2.800M | $2.700M | $1.489M |
Total Long-Term Liabilities | $0.00 | $0.00 | $1.900M |
Total Liabilities | $2.800M | $2.800M | $3.400M |
YoY Change | -28.21% | -17.65% | -58.54% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$51.72M | -$45.00M | |
YoY Change | 14.93% | 19.37% | |
Common Stock | $6.000K | $6.000K | $6.000K |
YoY Change | 0.0% | 100.0% | |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $4.000M | $3.233M | $7.611M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $6.700M | $5.985M | $10.96M |
YoY Change | -26.37% | -45.41% | 220.18% |
Cashflow Statement
Concept | 2017 Q2 | 2017 Q1 | 2016 Q1 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$4.092M | -$5.413M | -$1.189M |
YoY Change | 0.86% | 355.26% | -27.41% |
Depreciation, Depletion And Amortization | $60.00K | $43.00K | $102.0K |
YoY Change | -33.33% | -57.84% | 29.11% |
Cash From Operating Activities | -$2.750M | -$3.083M | -$2.110M |
YoY Change | 62.72% | 46.11% | 37.91% |
INVESTING ACTIVITIES | |||
Capital Expenditures | -$30.00K | $0.00 | $35.00K |
YoY Change | -85.71% | -100.0% | -2.78% |
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $0.00 | -$10.00K | $10.00K |
YoY Change | -100.0% | -200.0% | 0.0% |
Cash From Investing Activities | -$30.00K | -$9.000K | -$30.00K |
YoY Change | -86.36% | -70.0% | 0.0% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 3.850M | $4.816M | 7.730M |
YoY Change | 19150.0% | -37.7% | 294.39% |
NET CHANGE | |||
Cash From Operating Activities | -2.750M | -$3.083M | -2.110M |
Cash From Investing Activities | -30.00K | -$9.000K | -30.00K |
Cash From Financing Activities | 3.850M | $4.816M | 7.730M |
Net Change In Cash | 1.070M | $1.724M | 5.590M |
YoY Change | -156.61% | -69.16% | 1297.5% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$2.750M | -$3.083M | -$2.110M |
Capital Expenditures | -$30.00K | $0.00 | $35.00K |
Free Cash Flow | -$2.720M | -$3.083M | -$2.145M |
YoY Change | 83.78% | 43.73% | 36.97% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2017Q1 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
54945000 | USD |
CY2017Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-51718000 | USD |
CY2017Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
3233000 | USD |
CY2017Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
5985000 | USD |
CY2016Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
3872000 | USD |
CY2016Q1 | us-gaap |
Revenues
Revenues
|
568000 | USD |
CY2017Q1 | us-gaap |
Revenues
Revenues
|
1007000 | USD |
CY2017Q1 | us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
901000 | USD |
CY2016Q1 | us-gaap |
Gross Profit
GrossProfit
|
-102000 | USD |
CY2017Q1 | us-gaap |
Gross Profit
GrossProfit
|
106000 | USD |
CY2016Q1 | us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
670000 | USD |
CY2016Q1 | us-gaap |
Marketing And Advertising Expense
MarketingAndAdvertisingExpense
|
519000 | USD |
CY2017Q1 | us-gaap |
Marketing And Advertising Expense
MarketingAndAdvertisingExpense
|
1825000 | USD |
CY2016Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
905000 | USD |
CY2016Q4 | us-gaap |
Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
|
226000 | USD |
CY2016Q4 | us-gaap |
Accounts Payable Trade Current
AccountsPayableTradeCurrent
|
1812000 | USD |
CY2016Q4 | us-gaap |
Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
|
1113000 | USD |
CY2016Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
2925000 | USD |
CY2016Q4 | us-gaap |
Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
|
7488000 | USD |
CY2016Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
48413000 | USD |
CY2016Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-54960000 | USD |
CY2016Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-6541000 | USD |
CY2017Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
2017000 | USD |
CY2016Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
1821000 | USD |
CY2017Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
4311000 | USD |
CY2016Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1923000 | USD |
CY2016Q1 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
432000 | USD |
CY2017Q1 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-7460000 | USD |
CY2017Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-13000 | USD |
CY2017Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
7447000 | USD |
CY2017Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
3242000 | USD |
CY2016Q1 | drio |
Deemed Dividend Related To Exchange Agreement
DeemedDividendRelatedToExchangeAgreement
|
455000 | USD |
CY2017Q1 | drio |
Deemed Dividend Related To Exchange Agreement
DeemedDividendRelatedToExchangeAgreement
|
0 | USD |
CY2016Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-2823000 | USD |
CY2017Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
3242000 | USD |
CY2016Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.77 | |
CY2017Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
0.45 | |
CY2016Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
3652474 | shares |
CY2017Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
7195801 | shares |
CY2016 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
2277000 | USD |
CY2016 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
605000 | USD |
CY2016 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
1572000 | USD |
CY2016 | drio |
Stock Issued During Period Private Placement Value New Issues March2016
StockIssuedDuringPeriodPrivatePlacementValueNewIssuesMarch2016
|
828000 | USD |
CY2016 | drio |
Issuance Of Common Stock In January2016 To Service Provider
IssuanceOfCommonStockInJanuary2016ToServiceProvider
|
37000 | USD |
CY2016 | us-gaap |
Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
|
310000 | USD |
CY2016 | drio |
Stock Issued During Period Value Issued To Officer
StockIssuedDuringPeriodValueIssuedToOfficer
|
86000 | USD |
CY2016 | drio |
Stock Issued During Period Value Stock Warrants Exercised
StockIssuedDuringPeriodValueStockWarrantsExercised
|
210000 | USD |
CY2016 | drio |
Deemed Dividend Related To Change In Conversion Term Of Series Preferred Stock Value
DeemedDividendRelatedToChangeInConversionTermOfSeriesPreferredStockValue
|
0 | USD |
CY2016 | drio |
Deemed Dividend Related To Exchange Agreement Adjustment
DeemedDividendRelatedToExchangeAgreementAdjustment
|
0 | USD |
CY2017Q1 | us-gaap |
Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
|
1585000 | USD |
CY2016Q1 | us-gaap |
Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
|
324000 | USD |
CY2017Q1 | drio |
Increase Decrease In Accounts Receivables And Prepaid Expense
IncreaseDecreaseInAccountsReceivablesAndPrepaidExpense
|
210000 | USD |
CY2016Q1 | drio |
Increase Decrease In Accounts Receivables And Prepaid Expense
IncreaseDecreaseInAccountsReceivablesAndPrepaidExpense
|
-10000 | USD |
CY2017Q1 | us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
-328000 | USD |
CY2016Q1 | us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
-422000 | USD |
CY2017Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-3082000 | USD |
CY2016Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-2105000 | USD |
CY2016Q1 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-23000 | USD |
CY2017Q1 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
0 | USD |
CY2016Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
404000 | USD |
CY2017Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-39000 | USD |
CY2016Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-27000 | USD |
CY2017Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-9000 | USD |
CY2016Q1 | drio |
Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
|
7538000 | USD |
CY2017Q1 | drio |
Proceeds From Issuance Of Common Stock And Warrants
ProceedsFromIssuanceOfCommonStockAndWarrants
|
4816000 | USD |
CY2017Q1 | drio |
Proceeds From Stock Options And Warrants Exercised
ProceedsFromStockOptionsAndWarrantsExercised
|
0 | USD |
CY2016Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
7728000 | USD |
CY2017Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
4816000 | USD |
CY2016Q1 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
5596000 | USD |
CY2017Q1 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
1724000 | USD |
CY2015Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
2671000 | USD |
CY2016Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
8267000 | USD |
CY2016Q1 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
2277000 | USD |
CY2017Q1 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
0 | USD |
CY2016Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
35000 | USD |
CY2017Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
0 | USD |
CY2016Q1 | us-gaap |
Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
|
244000 | USD |
CY2017Q1 | us-gaap |
Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
|
262000 | USD |
CY2016Q1 | drio |
Payments For Proceeds From Acquire Leases Held For Investment
PaymentsForProceedsFromAcquireLeasesHeldForInvestment
|
-8000 | USD |
CY2017Q1 | drio |
Payments For Proceeds From Acquire Leases Held For Investment
PaymentsForProceedsFromAcquireLeasesHeldForInvestment
|
9000 | USD |
CY2016Q1 | drio |
Proceeds From Stock Options And Warrants Exercised
ProceedsFromStockOptionsAndWarrantsExercised
|
190000 | USD |
CY2017Q1 | us-gaap |
Depreciation
Depreciation
|
44000 | USD |
CY2016Q1 | us-gaap |
Depreciation
Depreciation
|
102000 | USD |
CY2017Q1 | us-gaap |
Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
|
256000 | USD |
CY2016Q1 | us-gaap |
Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
|
0 | USD |
CY2016Q4 | us-gaap |
Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
|
431000 | USD |
CY2016Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
457000 | USD |
CY2017Q1 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
425000 | USD |
CY2017Q1 | us-gaap |
Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
|
424000 | USD |
CY2017Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1585000 | USD |
CY2016Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
324000 | USD |
CY2016Q1 | drio |
Bank Charges
BankCharges
|
-4000 | USD |
CY2017Q1 | drio |
Bank Charges
BankCharges
|
-5000 | USD |
CY2016Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
9000 | USD |
CY2017Q1 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
8000 | USD |
CY2017Q1 | dei |
Document Type
DocumentType
|
10-Q | |
CY2017Q1 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2017Q1 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2017-03-31 | |
CY2017Q1 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2017 | |
CY2017Q1 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
CY2017Q1 | dei |
Entity Registrant Name
EntityRegistrantName
|
DarioHealth Corp. | |
CY2017Q1 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001533998 | |
CY2017Q1 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2017Q1 | dei |
Entity Filer Category
EntityFilerCategory
|
Smaller Reporting Company | |
CY2017Q1 | dei |
Trading Symbol
TradingSymbol
|
DRIO | |
CY2017Q2 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
9582377 | shares |
CY2017Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2016Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2016Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
160000000 | shares |
CY2017Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
160000000 | shares |
CY2017Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
7976521 | shares |
CY2017Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
7976521 | shares |
CY2016Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
5713383 | shares |
CY2016Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
5713383 | shares |
CY2017Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2016Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2017Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
CY2016Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
CY2016Q4 | us-gaap |
Temporary Equity Shares Issued
TemporaryEquitySharesIssued
|
0 | shares |
CY2016Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2017Q1 | us-gaap |
Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
|
0 | shares |
CY2016Q4 | us-gaap |
Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
|
0 | shares |
CY2017Q1 | us-gaap |
Basis Of Accounting
BasisOfAccounting
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;size: 8.5in 11.0in"> <table style="LINE-HEIGHT: 115%; WIDTH: 100%; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 0.3pt; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top"></td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; WIDTH: 0.75in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top" width="72"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt"> <b><font style="FONT-SIZE: 10pt">NOTE 3:-</font></b></div> </td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt" align="justify"><b><font style="FONT-SIZE: 10pt">UNAUDITED INTERIM FINANCIAL STATEMENTS</font></b></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: -28.35pt; MARGIN: 0in 0in 0pt 85.05pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 0.75in" align="justify"><font style="FONT-SIZE: 10pt">The accompanying unaudited interim consolidated financial statements as of March 31, 2017, have been prepared in accordance with U.S. generally accepted accounting principles and standards of the Public Company Accounting Oversight Board for interim financial information. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles in the United States for complete financial statements. In the opinion of management, the unaudited interim consolidated financial statements include all adjustments of a normal recurring nature necessary for a fair presentation of the Company's consolidated financial position as of March 31, 2017, and the Company's consolidated results of operations and the Company's consolidated cash flows for the three months ended March 31, 2017. Results for the three months ended March 31, 2017 are not necessarily indicative of the results that may be expected for the year ending December 31, 2017. </font></div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
CY2017Q1 | us-gaap |
Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
|
5100000 | USD |
CY2017Q1 | drio |
Stock Issued During Period Shares New Issues February2014
StockIssuedDuringPeriodSharesNewIssuesFebruary2014
|
1821437 | shares |
CY2015Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-1580000 | USD |
CY2017Q1 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
271000 | USD |
CY2017Q1 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2017Q1 | us-gaap |
Temporary Equity Shares Issued
TemporaryEquitySharesIssued
|
0 | shares |
CY2017Q1 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
|
1200000 | USD |
CY2017Q1 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P1Y3M18D | |
CY2017Q1 | us-gaap |
Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
|
482000 | USD |
CY2017Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
6000 | USD |
CY2016Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
6000 | USD |
CY2017Q1 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
CY2016Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
CY2017Q1 | drio |
Stock Issued During Period Private Placement Value New Issues January2017
StockIssuedDuringPeriodPrivatePlacementValueNewIssuesJanuary2017
|
2886000 | USD |
CY2017Q1 | us-gaap |
Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
|
250000 | USD |
CY2017Q1 | drio |
Issuance Of Common Stock In January2017 To Employees Value
IssuanceOfCommonStockInJanuary2017ToEmployeesValue
|
1198000 | USD |
CY2017Q1 | drio |
Issuance Of Common Stock In January2017 To Consultants And Service Provider Value
IssuanceOfCommonStockInJanuary2017ToConsultantsAndServiceProviderValue
|
49000 | USD |
CY2017Q1 | drio |
Stock Issued During Period Private Placement Value New Issues March2017
StockIssuedDuringPeriodPrivatePlacementValueNewIssuesMarch2017
|
1878000 | USD |
CY2017Q1 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
22000 | USD |
CY2016 | us-gaap |
Inventory Write Down
InventoryWriteDown
|
315000 | USD |
CY2016Q4 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
|
7488000 | USD |
CY2017Q1 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
|
-7460000 | USD |
CY2017Q1 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
|
28000 | USD |
CY2017Q1 | drio |
Payment For Directors And Management Under Shares For Cash Program
PaymentForDirectorsAndManagementUnderSharesForCashProgram
|
183000 | USD |
CY2016Q1 | drio |
Payment For Directors And Management Under Shares For Cash Program
PaymentForDirectorsAndManagementUnderSharesForCashProgram
|
51000 | USD |